Core Points - The stock price of Smart Agriculture dropped by 2.12% on October 30, trading at 3.23 CNY per share with a total market capitalization of 4.674 billion CNY [1] - The company has seen a year-to-date stock price increase of 6.95%, but a decline of 4.72% over the last five trading days [1] - For the period from January to September 2025, Smart Agriculture reported a revenue of 910 million CNY, a year-on-year decrease of 18.90%, and a net profit of 10.2527 million CNY, down 67.15% year-on-year [2] Financial Performance - As of September 30, the number of shareholders for Smart Agriculture was 126,900, a decrease of 12.36% from the previous period [2] - The company has cumulatively distributed 162 million CNY in dividends since its A-share listing, with no dividends distributed in the last three years [3] Business Overview - Smart Agriculture is primarily engaged in the manufacturing of internal combustion engines, generators, electric motors, water pumps, oil presses, and agricultural machinery [1] - The revenue composition of the company includes 64.22% from power and terminal products, 21.24% from metal mineral products, 13.22% from components, and 1.32% from agricultural information and other services [1]

Core Viewpoint - Fangsheng Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 23.28% and a recent decline of 2.06% on October 30, 2023, indicating market volatility and investor sentiment [1][2]. Financial Performance - For the period from January to September 2025, Fangsheng Pharmaceutical reported a revenue of 1.253 billion yuan, a year-on-year decrease of 7.02%, while the net profit attributable to shareholders increased by 17.60% to 268 million yuan [2]. - Cumulatively, the company has distributed 689 million yuan in dividends since its A-share listing, with 444 million yuan distributed over the past three years [3]. Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 6.50% to 31,000, while the average circulating shares per person increased by 6.96% to 14,167 shares [2]. - Notable changes in institutional holdings include the entry of new shareholders such as Rongtong China Wind No. 1 Flexible Allocation Mixed Fund and Changxin Jinli Trend Mixed Fund, while previous major shareholders like Industrial Bank Medical Care Stock have exited the top ten [3]. Market Activity - On October 30, 2023, Fangsheng Pharmaceutical's stock price was 12.34 yuan per share, with a trading volume of 66.89 million yuan and a turnover rate of 1.23%, reflecting active market participation [1]. - The stock has seen a net outflow of 6.5856 million yuan from major funds, indicating a cautious approach from institutional investors [1].

Core Viewpoint - Jianglong Shipbuilding experienced a decline in stock price, with a current trading price of 14.36 CNY per share, reflecting a 2.05% drop on October 30, 2023 [1] Group 1: Stock Performance - Year-to-date, Jianglong Shipbuilding's stock price has increased by 15.43%, with a 14.97% rise over the last five trading days and a 14.06% increase over the last twenty days, while it has decreased by 6.81% over the last sixty days [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on October 28, 2023, where it recorded a net purchase of 193 million CNY [1] Group 2: Financial Data - As of September 30, 2023, Jianglong Shipbuilding reported a revenue of 509 million CNY for the first nine months of 2023, representing a year-on-year decrease of 59.03%, and a net profit attributable to shareholders of -36.86 million CNY, a decline of 252.17% [2] - The company's main business revenue composition includes 56.43% from law enforcement vessels, 22.58% from leisure vessels, and 16.72% from special operation vessels [2] Group 3: Shareholder Information - As of September 30, 2023, Jianglong Shipbuilding had 30,300 shareholders, a decrease of 22.78% from the previous period, with an average of 7,649 circulating shares per shareholder, an increase of 29.50% [2] Group 4: Dividend Information - Since its A-share listing, Jianglong Shipbuilding has distributed a total of 34.85 million CNY in dividends, with 15.11 million CNY distributed over the last three years [3]

Core Viewpoint - Bichuang Technology's stock price has shown a modest increase this year, with a notable rise in recent trading days, despite a decline in revenue and net profit for the first nine months of 2025 [2][3]. Company Overview - Bichuang Technology, established on January 13, 2005, and listed on June 19, 2017, is located in Haidian District, Beijing. The company specializes in the research, production, and sales of industrial monitoring systems, testing and analysis systems, and MEMS sensor chips [2]. - The company's main revenue sources are: spectrometers (61.67%), smart sensors (22.76%), and precision optics (15.57%) [2]. Stock Performance - As of October 30, Bichuang Technology's stock price increased by 2.21%, reaching 16.66 CNY per share, with a market capitalization of 3.409 billion CNY [1]. - Year-to-date, the stock price has risen by 3.03%, with a 5-day increase of 5.38%, a 20-day increase of 4.85%, and a 60-day increase of 4.39% [2]. Financial Performance - For the period from January to September 2025, Bichuang Technology reported a revenue of 471 million CNY, a year-on-year decrease of 9.21%. The net profit attributable to shareholders was -11.9741 million CNY, representing a year-on-year decline of 218.10% [2]. Shareholder Information - As of October 20, 2025, the number of shareholders for Bichuang Technology was 19,600, a slight decrease of 0.09% from the previous period. The average number of circulating shares per shareholder increased by 0.09% to 8,805 shares [2]. - The company has distributed a total of 126 million CNY in dividends since its A-share listing, with 40.36 million CNY distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, the eighth largest circulating shareholder is GF Quantitative Multi-Factor Mixed A (005225), which holds 1.1653 million shares as a new shareholder [3].

Core Viewpoint - Shanghai Yashi's stock price has experienced fluctuations, with a year-to-date increase of 17.27% but a recent decline of 4.37% over the last five trading days [1] Group 1: Stock Performance - As of October 30, Shanghai Yashi's stock price was 11.60 CNY per share, with a market capitalization of 2.901 billion CNY [1] - The stock has seen a net outflow of 524.82 million CNY in principal funds, with significant selling activity [1] - The company has appeared on the trading leaderboard three times this year, with the most recent instance on April 11, where it recorded a net buy of -37.01 million CNY [1] Group 2: Company Overview - Shanghai Yashi Investment Development Co., Ltd. was established on May 22, 2003, and listed on December 29, 2017, focusing on supply chain logistics and execution trade [2] - The company's revenue composition includes 73.44% from supply chain execution trade and 25.97% from supply chain logistics [2] - The company operates within the transportation and logistics sector, specifically in raw material supply chain services [2] Group 3: Financial Performance - For the period from January to September 2025, Shanghai Yashi reported a revenue of 2.584 billion CNY, a year-on-year decrease of 15.54%, and a net profit of 25.84 million CNY, down 20.31% [2] - The company has distributed a total of 212 million CNY in dividends since its A-share listing, with 68.27 million CNY distributed over the past three years [3] - As of September 30, 2025, the number of shareholders decreased by 19.07% to 12,800, while the average circulating shares per person increased by 23.56% [2]

Core Viewpoint - The company, Chongqing Shanwaishan Blood Purification Technology Co., Ltd., has shown significant growth in revenue and net profit for the first nine months of 2025, indicating strong operational performance in the medical device sector [2]. Financial Performance - For the period from January to September 2025, the company achieved a revenue of 584 million yuan, representing a year-on-year growth of 39.79% [2]. - The net profit attributable to the parent company reached 104 million yuan, marking a year-on-year increase of 68.68% [2]. Stock Performance - As of October 30, the company's stock price decreased by 2.05%, trading at 16.26 yuan per share, with a total market capitalization of 5.225 billion yuan [1]. - Year-to-date, the stock price has increased by 47.02%, with a 11.91% rise over the last five trading days [1]. Shareholder Information - As of September 30, the number of shareholders increased to 10,300, a rise of 26.20% compared to the previous period [2]. - The average number of circulating shares per shareholder decreased by 20.76% to 22,805 shares [2]. Dividend Distribution - Since its A-share listing, the company has distributed a total of 104 million yuan in dividends [3]. Institutional Holdings - As of September 30, 2025, among the top ten circulating shareholders, Penghua Medical Technology Stock A is the fourth largest with 5.182 million shares, marking a new entry [3]. - Bosera Healthcare Mixed A remains the sixth largest shareholder, holding 3.257 million shares, unchanged from the previous period [3].

Core Viewpoint - Disen Co., Ltd. has experienced a decline in stock price recently, with a year-to-date increase of 28.39% and a notable drop in the last five trading days [1] Group 1: Company Overview - Disen Co., Ltd. is located in Guangzhou, Guangdong Province, and was established on July 16, 1996, with its listing date on July 10, 2012 [2] - The company specializes in providing thermal energy services using biomass fuel and other new clean energy sources [2] - The revenue composition includes: 45.15% from clean energy investment and operation (B-end), 36.47% from smart comfort home manufacturing and services (C-end), 15.05% from clean energy application equipment (B-end), and 3.32% from other sources [2] Group 2: Financial Performance - For the period from January to September 2025, Disen Co., Ltd. achieved an operating income of 788 million yuan, representing a year-on-year growth of 1.27%, and a net profit attributable to shareholders of 66.66 million yuan, up 3.05% year-on-year [2] - The company has distributed a total of 502 million yuan in dividends since its A-share listing, with 162 million yuan distributed over the past three years [3] Group 3: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased by 21.48% to 26,500, while the average circulating shares per person decreased by 17.68% to 14,490 shares [2] - The stock has seen significant trading activity, with a net outflow of 14.31 million yuan from main funds recently, and a notable presence on the trading leaderboard [1]

Core Viewpoint - Su Bote's stock price has experienced fluctuations, with a year-to-date increase of 39.81% but a recent decline in the last five trading days by 4.01% [1] Company Overview - Jiangsu Subote New Materials Co., Ltd. was established on December 15, 2004, and went public on November 10, 2017. The company specializes in the research, production, and sales of concrete additives [2] - The main revenue composition includes high-performance water reducers (51.83%), functional materials (20.74%), technical services (20.21%), and others [2] - As of September 30, the number of shareholders increased by 30.11% to 25,100, with an average of 16,761 circulating shares per person, a decrease of 23.14% [2] Financial Performance - For the period from January to September 2025, Su Bote achieved a revenue of 2.577 billion yuan, representing a year-on-year growth of 4.10%. The net profit attributable to shareholders was 94.12 million yuan, up 19.73% year-on-year [2] - The company has distributed a total of 740 million yuan in dividends since its A-share listing, with 234 million yuan distributed in the last three years [3] Shareholding Structure - As of September 30, 2025, the top ten circulating shareholders include a new entrant, the China Merchants Quantitative Selected Stock Fund (001917), holding 2.7122 million shares. The Nuoan Pioneer Mixed Fund (320003) has exited the top ten list [3]

Core Viewpoint - Keta Bio's stock price has shown fluctuations, with a year-to-date increase of 21.15% and a recent decline over the past 20 days, indicating mixed market sentiment towards the company [1][2]. Company Overview - Keta Bio, established on September 5, 2003, and listed on July 27, 2020, is located in Beijing and specializes in the research, production, and sales of food additives, probiotics, and micro-ecological preparations for plants and animals [1]. - The company's revenue composition includes 71.03% from probiotics, 16.96% from micro-ecological preparations, 11.14% from food additives, 0.73% from probiotic technology services, and 0.14% from other sources [1]. Financial Performance - For the period from January to September 2025, Keta Bio reported a revenue of 267 million yuan, reflecting a year-on-year growth of 22.25%, while the net profit attributable to shareholders was 76.23 million yuan, up 7.08% year-on-year [2]. - Since its A-share listing, Keta Bio has distributed a total of 289 million yuan in dividends, with 132 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, Keta Bio had 17,100 shareholders, an increase of 5.63% from the previous period, with an average of 11,343 circulating shares per shareholder, down 5.33% [2]. - Among the top ten circulating shareholders, the "Fuguo Growth Navigation Mixed Fund" holds 6.6083 million shares, unchanged from the previous period, while the "Fuguo Balanced Preferred Mixed Fund" reduced its holdings by 3.1617 million shares to 4.2466 million shares [3].

Core Points - The stock price of New Dazheng has decreased by 2.00% to 12.25 CNY per share as of October 30, with a market capitalization of 2.772 billion CNY [1] - Year-to-date, New Dazheng's stock price has increased by 37.22%, but it has seen a decline of 4.30% in the last five trading days [2] - The company reported a revenue of 2.272 billion CNY for the first nine months of 2025, a year-on-year decrease of 11.82%, and a net profit of 104 million CNY, down 2.97% year-on-year [2] Financial Performance - New Dazheng's main business revenue composition includes: basic services 87.79%, urban services 8.22%, innovative services 3.86%, and others 0.13% [2] - The company has distributed a total of 381 million CNY in dividends since its A-share listing, with 197 million CNY distributed in the last three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders for New Dazheng increased by 6.68% to 15,200, while the average circulating shares per person decreased by 6.26% to 14,059 shares [2] - The seventh largest circulating shareholder is Dongfanghong Yuanjian Value Mixed A, holding 2.8237 million shares, an increase of 90,100 shares from the previous period [3]